Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Expert Review of Anticancer Therapy
|
June 20, 2020
The emerging role of antibody-drug conjugates in urothelial carcinoma
Michael Lattanzi, Jonathan E Rosenberg
Current Oncology Reports
|
February 27, 2019
Current Status and Future Direction of Immunotherapy in Urothelial Carcinoma
Michael Lattanzi, Arjun V Balar
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 24, 2022
Reply to S. Zhang
Michael Lattanzi, Samuel A Funt, Jonathan E Rosenberg
Journal of Clinical Medicine
|
October 26, 2024
Clinical Meaningfulness of an Algorithm-Based Service for Analyzing Treatment Response in Patients with Metastatic Cancer Using FDG PET/CT
Manojkumar Bupathi, Benjamin Garmezy, Michael Lattanzi, et al.
Journal for Immunotherapy of Cancer
|
May 19, 2018
Adjuvant NY-ESO-1 vaccine immunotherapy in high-risk resected melanoma: a retrospective cohort analysis
Michael Lattanzi, Joseph Han, Una Moran, et al.
Journal for Immunotherapy of Cancer
|
October 5, 2018
Durable response to anti-PD-1 immunotherapy in epithelioid angiomyolipoma: a report on the successful treatment of a rare malignancy
Michael Lattanzi, Fang-Ming Deng, Luis A Chiriboga, et al.
Cancer Immunology Research
|
November 9, 2019
Combined Vaccination with NY-ESO-1 Protein, Poly-ICLC, and Montanide Improves Humoral and Cellular Immune Responses in Patients with High-Risk Melanoma
Anna Pavlick, Ana B Blazquez, Marcia Meseck, et al.
Journal of the National Cancer Institute
|
June 19, 2018
Primary Melanoma Histologic Subtype: Impact on Survival and Response to Therapy
Michael Lattanzi, Yesung Lee, Danny Simpson, et al.
JCO Oncology Practice
|
June 16, 2025
Quality of Informed Consent via Telemedicine Compared With In-Person for Clinical Cancer Research
Michal Sternschuss, Michael Lattanzi, Emily Vertosick, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 8, 2023
Clinical and Genomic Landscape of FGFR3-Altered Urothelial Carcinoma and Treatment Outcomes with Erdafitinib: A Real-World Experience
Brendan J Guercio, Michal Sarfaty, Min Yuen Teo, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Expert Review of Anticancer Therapy
|
June 20, 2020
The emerging role of antibody-drug conjugates in urothelial carcinoma
Michael Lattanzi, Jonathan E Rosenberg
Current Oncology Reports
|
February 27, 2019
Current Status and Future Direction of Immunotherapy in Urothelial Carcinoma
Michael Lattanzi, Arjun V Balar
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 24, 2022
Reply to S. Zhang
Michael Lattanzi, Samuel A Funt, Jonathan E Rosenberg
Journal of Clinical Medicine
|
October 26, 2024
Clinical Meaningfulness of an Algorithm-Based Service for Analyzing Treatment Response in Patients with Metastatic Cancer Using FDG PET/CT
Manojkumar Bupathi, Benjamin Garmezy, Michael Lattanzi, et al.
Journal for Immunotherapy of Cancer
|
May 19, 2018
Adjuvant NY-ESO-1 vaccine immunotherapy in high-risk resected melanoma: a retrospective cohort analysis
Michael Lattanzi, Joseph Han, Una Moran, et al.
Journal for Immunotherapy of Cancer
|
October 5, 2018
Durable response to anti-PD-1 immunotherapy in epithelioid angiomyolipoma: a report on the successful treatment of a rare malignancy
Michael Lattanzi, Fang-Ming Deng, Luis A Chiriboga, et al.
Cancer Immunology Research
|
November 9, 2019
Combined Vaccination with NY-ESO-1 Protein, Poly-ICLC, and Montanide Improves Humoral and Cellular Immune Responses in Patients with High-Risk Melanoma
Anna Pavlick, Ana B Blazquez, Marcia Meseck, et al.
Journal of the National Cancer Institute
|
June 19, 2018
Primary Melanoma Histologic Subtype: Impact on Survival and Response to Therapy
Michael Lattanzi, Yesung Lee, Danny Simpson, et al.
JCO Oncology Practice
|
June 16, 2025
Quality of Informed Consent via Telemedicine Compared With In-Person for Clinical Cancer Research
Michal Sternschuss, Michael Lattanzi, Emily Vertosick, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 8, 2023
Clinical and Genomic Landscape of FGFR3-Altered Urothelial Carcinoma and Treatment Outcomes with Erdafitinib: A Real-World Experience
Brendan J Guercio, Michal Sarfaty, Min Yuen Teo, et al.
Page
of 2